Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Abbott Will Grow Zemplar Sales With Oral Formulation, Predialysis Use

Apr 09 2004

• By Sue Sutter

Related Content

Genzyme Renagel Marketing Message Will Focus On Lipid-Lowering Effect

Feb 19 2004

Amgen Sensipar Approved; Target U.S. Market At Least 300,000 Patients

Mar 09 2004

Sensipar Label Has Precautions On Hypocalcemia; Pre-Dialysis Indication Could Be Challenge

Mar 09 2004

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window